SEC Form 4 · accession 0001209191-15-012581
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen L. Zaderej
Officer — Chief Executive Officer · Director
Period of report
Feb 10, 2015
Accepted (ET)
Feb 12, 2015 · 3:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 10, 2015 | A | 9,600 | $2.75 | A | 228,822 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person purchased these shares in their individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On February 5, 2015, the trade date for the public offering, the closing sale price reported by NASDAQ was $3.16 per share. The public offering closed on February 10, 2015, and the closing sale price reported by NASDAQ on such date was $3.18 per share.